Verastem (VSTM) Equity Average (2012 - 2026)
Verastem (VSTM) recorded quarterly Equity Average of $69.5 million in Q1 2026, up 233.5% quarter-over-quarter from $20.8 million in Q4 2025, and up 326.62% on a YoY basis from $16.3 million in Q1 2025.
Verastem (VSTM) Equity Average (2012 - 2026) Analysis & Trends
Verastem's Equity Average history runs 15 years deep, the most recent figure standing at $69.5 million for Q1 2026.
- In Q1 2026, Equity Average rose 326.62% year-over-year to $69.5 million; the TTM figure through Mar 2026 stood at $69.5 million (up 326.62% YoY), while the FY2025 annual figure was $14.2 million, down 0.62% from the prior year.
- Equity Average was $69.5 million for Q1 2026 at Verastem, up from $20.8 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $92.4 million in Q3 2023 to a low of -$30.7 million in Q1 2025.
- Historically, Equity Average has averaged $39.3 million across 5 years, with a median of $41.2 million in 2024.
- Biggest YoY gain for Equity Average was 333.67% in 2025; the steepest drop was 174.39% in 2025.
- A 5-year view of Equity Average shows it stood at $55.1 million in 2022, then advanced by 27.47% to $70.3 million in 2023, then plunged by 112.69% to -$8.9 million in 2024, then soared by 333.67% to $20.8 million in 2025, then surged by 233.5% to $69.5 million in 2026.
- The last three Equity Average figures came in at $69.5 million (Q1 2026), $20.8 million (Q4 2025), and $10.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn | 69.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.49 Mn |
| Dec 31, 2025 | 20.84 Mn |
| Sep 30, 2025 | 10.27 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | -30.66 Mn |
| Dec 31, 2024 | -8.92 Mn |
| Sep 30, 2024 | 14.96 Mn |
| Jun 30, 2024 | 21.96 Mn |
| Mar 31, 2024 | 41.22 Mn |
| Dec 31, 2023 | 70.28 Mn |
| Sep 30, 2023 | 92.39 Mn |
| Jun 30, 2023 | 67.31 Mn |
| Mar 31, 2023 | 40.21 Mn |
| Dec 31, 2022 | 55.13 Mn |
| Sep 30, 2022 | 58.38 Mn |
| Jun 30, 2022 | 63.33 Mn |
| Mar 31, 2022 | 80.17 Mn |
| Dec 31, 2021 | 91.61 Mn |
| Sep 30, 2021 | 91.93 Mn |
| Jun 30, 2021 | 95.41 Mn |